Ngā hua rapu - Wan, Zhiyong

Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling mā He, Shanyang, Zhao, Yunhe, Wang, Xiaoping, Deng, Yalan, Wan, Zhiyong, Yao, Shuzhong, Shen, Hongwei

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway mā He, Shanyang, Niu, Gang, Shang, Jianhong, Deng, Yalan, Wan, Zhiyong, Zhang, Cai, You, Zeshan, Shen, Hongwei

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway mā He, Shanyang, Wang, Wei, Wan, Zhiyong, Shen, Hongwei, Zhao, Yunhe, You, Zeshan, Liu, Jun, Zhu, Liwen

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Correction to: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway mā He, Shanyang, Wang, Wei, Wan, Zhiyong, Shen, Hongwei, Zhao, Yunhe, You, Zeshan, Liu, Jun, Zhu, Liwen

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer mā Shen, Hongwei, Liao, Bing, Wan, Zhiyong, Zhao, Yunhe, You, Zeshan, Liu, Jun, Lan, Jin, He, Shanyang

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy mā Xue, Peng, Zhu, Lifei, Wan, Zhiyong, Huang, Weiyi, Li, Ning, Chen, Donghui, Hu, Jiong, Yang, Haiyan, Wang, Liwei

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa